Donna Roy Grogan - Jul 1, 2025 Form 4 Insider Report for C4 Therapeutics, Inc. (CCCC)

Role
Director
Signature
/s/ Jolie M. Siegel, Attorney-in-Fact
Stock symbol
CCCC
Transactions as of
Jul 1, 2025
Transactions value $
$14,510
Form type
4
Date filed
7/2/2025, 04:17 PM
Previous filing
Jun 20, 2025
Next filing
Oct 3, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
GROGAN DONNA ROY Director C/O C4 THERAPEUTICS, INC., 490 ARSENAL WAY #120, WATERTOWN /s/ Jolie M. Siegel, Attorney-in-Fact 2025-07-02 0001788455

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CCCC Common Stock Award $14.5K +9.61K +22.73% $1.51 51.9K Jul 1, 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer.
F2 The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on July 1, 2025.